Stocks To Watch: HDFC Bank, Macrotech Developers, Glenmark Pharma
Business | Edited by Peter Noronha | Monday April 19, 2021
HDFC Bank reported net profit of Rs 8,186.51 crore in the January-March quarter, an increase of 18.2 per cent compared to Rs 6,927.69 crore during the same period last year
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Business | Edited by Peter Noronha | Wednesday November 11, 2020
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
Glenmark Shares Surge Over 35% On Regulatory Approval For COVID-19 Drug
Business | Edited by Abhishek Vasudev | Monday June 22, 2020
Favipiravir being manufactured by Glenmark will be marketed by the name of Fabiflu and will be available in strength of 200 milligrams.
Glenmark Gets Approval For Favipiravir As COVID-19 Treatment
Business | Reuters | Friday June 19, 2020
Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.
Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump
Business | Reuters | Thursday April 30, 2020
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.
Glenmark Pharma Receives 7 Observations From US Regulator On Baddi Unit, Shares Fall
Business | NDTV Profit Team | Tuesday November 28, 2017
Glenmark Pharmaceuticals said the Baddi unit contributes approximately 10 per cent of the revenue of US sales.
Trading Calls: Buy Glenmark Pharma, Tata Chemicals, Bosch, Vedanta, Say Experts
Business | NDTV Profit Team | Tuesday November 21, 2017
On Monday, domestic shares slightly higher with the NSE benchmark index Nifty rising 15 points, or 0.14 per cent, to close at 10,298 and the BSE Sensex settling up 17 points, or 0.05 per cent, at 33,359.
Glenmark Pharma Gets USFDA Nod For Hypertension Medicine
Business | Press Trust of India | Friday July 7, 2017
According to IMS Health sales data for the 12 months to May 2017, Azor tablets achieved annual sales of approximately $211.6 million, Glenmark said.
Sensex Falls 63 Points, Nifty Settles Above 9,400; Yes Bank Plunges 6%
Business | NDTV Profit Team | Friday May 12, 2017
IT shares like, Infosys, Tech Mahindra, HCL Tech were among the major gainers in the Nifty today rising between 1-2.2 per cent. The Nifty IT, NSE's sub-index for IT shares rose 1.18 per cent.
Trading Calls: Buy Coal India, Aurobindo Pharma, Heidelberg Cement, Say Experts
Business | Edited by Surajit Dasgupta | Friday February 3, 2017
Some analysts say gains could be capped in the near term given the sharp rally in recent sessions.
Glenmark Q3 Net Up Over Two-Fold To Rs 477 Crore
Business | Press Trust of India | Thursday February 2, 2017
During the quarter, the company announced its strategic blueprint for the next decade where the organisation's focus will be directed to three therapeutic areas, namely oncology, respiratory and dermatology.
Buy Glenmark, Hold PNB, Avoid Lupin: Pradip Hotchandani
Business | Edited by Abhishek Vasudev | Tuesday November 8, 2016
Nifty is likely to go down 8,325 and on the upside it faces resistance around 8,560 levels, says Pradip Hotchandani, head of research at Prudent Broking Services.
Buy Ujaas Energy, Glenmark Pharma; Avoid Just Dial: Pradip Hotchandani
Business | Edited by Abhishek Vasudev | Thursday November 3, 2016
The stock markets witnessed heavy selling in trades on Wednesday wherein the Sensex slumped nearly 350 points and Nifty settled below its crucial psychological level on 8,550.
Glenmark Pharma Shares Gain Over 4% Post Q2 Results
Business | Press Trust of India | Friday October 28, 2016
Glenmark's consolidated revenue was up 16.48 per cent to Rs 2,224.10 crore during the quarter under review as against Rs 1,909.36 in the same period last year.
Glenmark Pharma Q2 Profit Rises 3% To Rs 223 Crore
Business | Press Trust of India | Thursday October 27, 2016
The pharmaceuticals company had reported a net profit of Rs 216.10 crore for the corresponding period of the previous fiscal year.
India business robust in terms of growth: Glenmark on Q1 results
Aug 2, 2013
Avoid aviation stocks, buy pharma, realty stocks: Experts
Nov 21, 2012
Positve on Wockhardt, Glenmark Pharma: Anand Bagaria
Nov 15, 2012
Why real estate stocks fell 5%
Oct 11, 2012
Budget to boost market; stick to pharma, auto stocks: Market experts
Feb 23, 2012
Buy select pharma and FMCG stocks: Anand Rathi
Aug 26, 2011
Buy Maruti with a target of Rs 1580: UBS
Jun 17, 2011
Glenmark gets licensing deal boost
May 16, 2011
Glenmark Pharma net up 38%
Oct 27, 2010
Glenmark cuts two deals with Medicis
Nov 23, 2009
Glenmark revives IPO plans
Oct 1, 2009
Earnings call: Glenmark Pharma
Jan 27, 2009
Glenmark pained by pain drug
Oct 24, 2008
Stocks To Watch: HDFC Bank, Macrotech Developers, Glenmark Pharma
Business | Edited by Peter Noronha | Monday April 19, 2021
HDFC Bank reported net profit of Rs 8,186.51 crore in the January-March quarter, an increase of 18.2 per cent compared to Rs 6,927.69 crore during the same period last year
Glenmark Pharma Gets Regulatory Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
Business | Edited by Peter Noronha | Wednesday November 11, 2020
Glenmark Pharma received final approval from USFDA for Tacrolimus capsules, which are used as immunosuppressants to prevent human immune system from rejecting liver, kidney and heart transplants.
Glenmark Shares Surge Over 35% On Regulatory Approval For COVID-19 Drug
Business | Edited by Abhishek Vasudev | Monday June 22, 2020
Favipiravir being manufactured by Glenmark will be marketed by the name of Fabiflu and will be available in strength of 200 milligrams.
Glenmark Gets Approval For Favipiravir As COVID-19 Treatment
Business | Reuters | Friday June 19, 2020
Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.
Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump
Business | Reuters | Thursday April 30, 2020
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.
Glenmark Pharma Receives 7 Observations From US Regulator On Baddi Unit, Shares Fall
Business | NDTV Profit Team | Tuesday November 28, 2017
Glenmark Pharmaceuticals said the Baddi unit contributes approximately 10 per cent of the revenue of US sales.
Trading Calls: Buy Glenmark Pharma, Tata Chemicals, Bosch, Vedanta, Say Experts
Business | NDTV Profit Team | Tuesday November 21, 2017
On Monday, domestic shares slightly higher with the NSE benchmark index Nifty rising 15 points, or 0.14 per cent, to close at 10,298 and the BSE Sensex settling up 17 points, or 0.05 per cent, at 33,359.
Glenmark Pharma Gets USFDA Nod For Hypertension Medicine
Business | Press Trust of India | Friday July 7, 2017
According to IMS Health sales data for the 12 months to May 2017, Azor tablets achieved annual sales of approximately $211.6 million, Glenmark said.
Sensex Falls 63 Points, Nifty Settles Above 9,400; Yes Bank Plunges 6%
Business | NDTV Profit Team | Friday May 12, 2017
IT shares like, Infosys, Tech Mahindra, HCL Tech were among the major gainers in the Nifty today rising between 1-2.2 per cent. The Nifty IT, NSE's sub-index for IT shares rose 1.18 per cent.
Trading Calls: Buy Coal India, Aurobindo Pharma, Heidelberg Cement, Say Experts
Business | Edited by Surajit Dasgupta | Friday February 3, 2017
Some analysts say gains could be capped in the near term given the sharp rally in recent sessions.
Glenmark Q3 Net Up Over Two-Fold To Rs 477 Crore
Business | Press Trust of India | Thursday February 2, 2017
During the quarter, the company announced its strategic blueprint for the next decade where the organisation's focus will be directed to three therapeutic areas, namely oncology, respiratory and dermatology.
Buy Glenmark, Hold PNB, Avoid Lupin: Pradip Hotchandani
Business | Edited by Abhishek Vasudev | Tuesday November 8, 2016
Nifty is likely to go down 8,325 and on the upside it faces resistance around 8,560 levels, says Pradip Hotchandani, head of research at Prudent Broking Services.
Buy Ujaas Energy, Glenmark Pharma; Avoid Just Dial: Pradip Hotchandani
Business | Edited by Abhishek Vasudev | Thursday November 3, 2016
The stock markets witnessed heavy selling in trades on Wednesday wherein the Sensex slumped nearly 350 points and Nifty settled below its crucial psychological level on 8,550.
Glenmark Pharma Shares Gain Over 4% Post Q2 Results
Business | Press Trust of India | Friday October 28, 2016
Glenmark's consolidated revenue was up 16.48 per cent to Rs 2,224.10 crore during the quarter under review as against Rs 1,909.36 in the same period last year.
Glenmark Pharma Q2 Profit Rises 3% To Rs 223 Crore
Business | Press Trust of India | Thursday October 27, 2016
The pharmaceuticals company had reported a net profit of Rs 216.10 crore for the corresponding period of the previous fiscal year.
India business robust in terms of growth: Glenmark on Q1 results
Aug 2, 2013
Avoid aviation stocks, buy pharma, realty stocks: Experts
Nov 21, 2012
Positve on Wockhardt, Glenmark Pharma: Anand Bagaria
Nov 15, 2012
Why real estate stocks fell 5%
Oct 11, 2012
Budget to boost market; stick to pharma, auto stocks: Market experts
Feb 23, 2012
Buy select pharma and FMCG stocks: Anand Rathi
Aug 26, 2011
Buy Maruti with a target of Rs 1580: UBS
Jun 17, 2011
Glenmark gets licensing deal boost
May 16, 2011
Glenmark Pharma net up 38%
Oct 27, 2010
Glenmark cuts two deals with Medicis
Nov 23, 2009
Glenmark revives IPO plans
Oct 1, 2009
Earnings call: Glenmark Pharma
Jan 27, 2009
Glenmark pained by pain drug
Oct 24, 2008
................................ Advertisement ................................
................................ Advertisement ................................
